المؤلفون: John Landry, Shweta Urva, Jennifer A. Martin, Tonya Quinlan, Corina Loghin

المصدر: Clinical Pharmacokinetics

مصطلحات موضوعية: Agonist, medicine.medical_specialty, medicine.drug_class, medicine.medical_treatment, Cmax, Urology, Renal function, 030209 endocrinology & metabolism, Gastric Inhibitory Polypeptide, Type 2 diabetes, urologic and male genital diseases, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Humans, Medicine, Pharmacology (medical), Original Research Article, 030212 general & internal medicine, Dialysis, Pharmacology, business.industry, medicine.disease, Confidence interval, Diabetes Mellitus, Type 2, Pharmaceutical Preparations, Tolerability, Area Under Curve, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f376f4d33db2465f81512718ac090f49Test
https://doi.org/10.1007/s40262-021-01012-2Test

المؤلفون: Jennifer N. Clements, Diana Isaacs, Sylvie F. Hall

المصدر: Clinical Pharmacokinetics. 57:1529-1538

مصطلحات موضوعية: Injections, Subcutaneous, Glucagon-Like Peptides, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Pharmacology, Hypoglycemia, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, medicine, Animals, Humans, Hypoglycemic Agents, Pharmacology (medical), Glucagon-like peptide 1 receptor, Glycated Hemoglobin, Dose-Response Relationship, Drug, Gastric emptying, Insulin glargine, business.industry, Semaglutide, Body Weight, medicine.disease, Diabetes Mellitus, Type 2, Sitagliptin, business, Exenatide, Half-Life, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a87897d40cdcc1548799147d61295f0Test
https://doi.org/10.1007/s40262-018-0668-zTest

المؤلفون: Prajakti A. Kothare, Kenneth F. Mace, Wen-I Li, Kristin Taylor, Brandon Walsh, Mark Fineman, Brenda Cirincione, Maria Aisporna, Michaela Diamant, Leigh MacConell, Shawn Flanagan, Larry Z. Shen

المساهمون: Internal medicine, EMGO - Lifestyle, overweight and diabetes, ICaR - Ischemia and repair

المصدر: Clinical Pharmacokinetics, 50(1), 65-74. Adis International Ltd
Fineman, M, Flanagan, S, Taylor, K, Aisporna, M, Shen, L Z, Mace, K F, Walsh, B, Diamant, M, Cirincione, B, Kothare, P, Li, W I & MacConell, L 2011, ' Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing ', Clinical Pharmacokinetics, vol. 50, no. 1, pp. 65-74 . https://doi.org/10.2165/11585880-000000000-00000Test

مصطلحات موضوعية: Blood Glucose, Male, medicine.medical_specialty, Injections, Subcutaneous, Population, Incretin, Pharmacology, Drug Administration Schedule, Glucagon-Like Peptide-1 Receptor, Pharmacokinetics, Glucagon-Like Peptide 1, Internal medicine, Receptors, Glucagon, medicine, Humans, Hypoglycemic Agents, Pharmacology (medical), education, education.field_of_study, Dose-Response Relationship, Drug, Gastric emptying, Venoms, business.industry, Glucagon secretion, Middle Aged, Endocrinology, Postprandial, Diabetes Mellitus, Type 2, Gastric Emptying, Delayed-Action Preparations, Pharmacodynamics, Exenatide, Peptides, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9052d7fde6d5811c9d458f48d5417467Test
https://doi.org/10.2165/11585880-000000000-00000Test